Neurodevelopmental disorders encompass a wide range of conditions that affect brain development, often presenting early in life and impacting cognitive, social, and motor functions. Autism spectrum disorder, attention-deficit hyperactivity disorder (ADHD), and intellectual disabilities are among the most commonly studied conditions in this category. Research is increasingly focusing on the genetic, environmental, and neurobiological factors that contribute to these disorders, with an emphasis on early diagnosis and intervention. Advances in neuroimaging and molecular genetics are helping to identify biomarkers and potential therapeutic targets. Early interventions, including behavioral therapies and pharmacological treatments, aim to support children’s development and improve their quality of life. Additionally, the growing field of personalized medicine holds promise for more tailored and effective treatments for individuals with neurodevelopmental disorders.
Title : Perception and individuality
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Psychogenic Non-Epileptic Seizures (PNES) also known as Functional Seizures (FS)
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Futurey on neurology
Luiz Moutinho, University of Suffolk, United Kingdom
Title : The foundation and architecture of Personalized & Precision Medicine (PPM) in clinical neurology: Towards curative and neurodegenerative disease-modifying treatment for multiple sclerosis
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Predictors of neurological recovery following traumatic spinal cord
W S El Masri, Keele University, United Kingdom
Title : The vision neurology as bio-recursion and brain-blockchain
Dobilas Kirvelis, Lithuanian Scientific Society, Lithuania